DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Romania
  • /
  • Pharmaceuticals & Biotech
Author Program NEWCreate Narrative
SINT logo

S.C. Sintofarm S.A. Stock Price

BVB:SINT Community·RON 42.5m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

SINT Share Price Performance

RON 11.00
7.50 (214.29%)
​
RON 11.00
7.50 (214.29%)
​
Price RON 11.00
Sat, 12 Sep 26
Share Pricen/a

SINT Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with slight risk.

4 Risks
0 Rewards
View Full Analysis

S.C. Sintofarm S.A. Key Details

RON 12.0m

Revenue

RON 2.9m

Cost of Revenue

RON 9.0m

Gross Profit

RON 9.5m

Other Expenses

-RON 518.9k

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
-0.13
75.45%
-4.34%
0%
View Full Analysis

About SINT

Founded
1916
Employees
47
CEO
n/a
WebsiteView website
sintofarm.ro

S.C. Sintofarm S.A. manufactures and sells pharmaceutical preparations in Romania. The company offers medicines for human use; medical devices; cosmetic products; biocidal disinfectants; food supplements; and other chemical products. It engages in research and exploitation; and import and export activities. S.C. Sintofarm S.A. was founded in 1916 and is based in Bucharest, Romania.

Recent SINT News & Updates

Recent updates

No updates

S.C. Sintofarm S.A. Competitors

View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide